1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome : a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry
2024) In Heart(
- Contribution to journal › Article
- 2023
-
Mark
Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention : A Substudy of VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
- 2021
-
Mark
Outcome of PCI with Xience versus other commonly used modern drug eluting stents : A SCAAR report
(
- Contribution to journal › Article
-
Mark
Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent : a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Article
- 2020
-
Mark
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical use of cangrelor : nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
(
- Contribution to journal › Article
- 2017
-
Mark
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold : Data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article